A Study of PRL3-zumab in Neovascular Age-related Macular Degeneration (nAMD)

NCT07547228 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular Age Related Macular Degeneration

Interventions

BIOLOGICAL: PRL3-ZUMAB
OTHER: Normal Saline (0.9% Sodium Chloride)

Sponsor

Intra-IMMUSG Pte Ltd

Collaborators

[object Object]